For US residents only.
A comprehensive biomarker test can help you and your doctor zero in on the right metastatic non-small cell lung cancer (mNSCLC) treatment for you.
Ask your doctor to test for different traits of your specific type of cancer, such as PD-L1 levels or mutations like EGFR, ALK, and METex14.
ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; MET, mesenchymal-epithelial transition; METex14, MET exon 14 skipping; PD-L1, programmed death-ligand 1.
Your test results may help your doctor find a treatment path specific to your mNSCLC, whether it includes targeted therapy or not.